INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP)

CUSIP: 46137V662

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / PHARMACEUTICALS
Total 13F shares
1,386,375
Share change
+3,612
Total reported value
$89,733,993
Price per share
$64.72
Number of holders
85
Value change
+$423,042
Number of buys
32
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 46137V662?
CUSIP 46137V662 identifies PJP - INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) as of Q2 2020

As of 30 Jun 2020, INVESCO EXCHANGE TRADED FD T - PHARMACEUTICALS (PJP) was held by 85 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,386,375 shares. The largest 10 holders included CLS Investments, LLC, ENVESTNET ASSET MANAGEMENT INC, Peak Asset Management, LLC, BANK OF AMERICA CORP /DE/, LPL Financial LLC, ROYAL BANK OF CANADA, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, UBS Group AG, and Advocacy Wealth Management Services, LLC. This page lists 85 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.